EoPancreas: New Diabetes Patch Pump and CGM System in Development

FDA has granted "Breakthrough Device Designation" to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.
FDA has granted Breakthrough Device Designation to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.

December update on closed-loop systems

Quarterly Update Diabetes Technology

December update on closed-loop systems

Artificial Pancreas aka Automated Insulin Delivery: What You Should

Artificial Pancreas aka Automated Insulin Delivery: What You Should

Omnipod CGM and Pump Patch - Diabetes UK Shop

Diabetes Management with Insulin Pumps and CGMs (Continuous Glucose Monitors)

Diabetes Management with Insulin Pumps and CGMs (Continuous Glucose Monitors)

Artificial Pancreas Improves Glycemic Control in Young Kids With T1D

Diabetes Café (@Diabetesto) / X

Omnipod CGM and Pump Patch - Diabetes UK Shop

The Future of Closed-Loop Systems